Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria, Falciparum | 22 | 2024 | 119 | 3.620 |
Why?
|
| Plasmodium falciparum | 22 | 2024 | 134 | 2.980 |
Why?
|
| Antimalarials | 12 | 2024 | 67 | 2.150 |
Why?
|
| Drug Resistance | 12 | 2024 | 95 | 1.730 |
Why?
|
| Malaria | 5 | 2024 | 101 | 0.950 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 264 | 0.610 |
Why?
|
| Mutation | 4 | 2020 | 2462 | 0.410 |
Why?
|
| Uganda | 8 | 2024 | 33 | 0.400 |
Why?
|
| Folic Acid Antagonists | 2 | 2022 | 4 | 0.380 |
Why?
|
| Democratic Republic of the Congo | 4 | 2020 | 8 | 0.280 |
Why?
|
| Sulfadoxine | 4 | 2020 | 5 | 0.280 |
Why?
|
| Genome, Protozoan | 2 | 2024 | 5 | 0.280 |
Why?
|
| Plasmodium ovale | 1 | 2024 | 2 | 0.240 |
Why?
|
| Protozoan Proteins | 5 | 2024 | 86 | 0.230 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 17 | 0.230 |
Why?
|
| Bacillus thuringiensis | 1 | 2024 | 20 | 0.230 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 16 | 0.230 |
Why?
|
| Proviruses | 1 | 2024 | 26 | 0.220 |
Why?
|
| Artemisinins | 2 | 2021 | 13 | 0.220 |
Why?
|
| Hemolysin Proteins | 1 | 2024 | 44 | 0.220 |
Why?
|
| Endotoxins | 1 | 2024 | 78 | 0.220 |
Why?
|
| Introns | 1 | 2024 | 104 | 0.220 |
Why?
|
| Parasites | 1 | 2023 | 10 | 0.210 |
Why?
|
| Culicidae | 1 | 2023 | 8 | 0.210 |
Why?
|
| Humans | 26 | 2024 | 59744 | 0.210 |
Why?
|
| Thermogenesis | 1 | 2024 | 116 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 111 | 0.210 |
Why?
|
| Genotype | 5 | 2024 | 621 | 0.210 |
Why?
|
| RNA, Viral | 1 | 2024 | 259 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2024 | 185 | 0.200 |
Why?
|
| Proteasome Inhibitors | 1 | 2022 | 30 | 0.200 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 43 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 1 | 2023 | 203 | 0.180 |
Why?
|
| Aminoquinolines | 1 | 2021 | 15 | 0.180 |
Why?
|
| Naphthoquinones | 1 | 2021 | 5 | 0.180 |
Why?
|
| Dendritic Cells | 1 | 2024 | 515 | 0.180 |
Why?
|
| Pyrimethamine | 4 | 2022 | 7 | 0.180 |
Why?
|
| Chloroquine | 4 | 2021 | 50 | 0.170 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2024 | 397 | 0.170 |
Why?
|
| Drug Combinations | 4 | 2021 | 147 | 0.170 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 57 | 0.160 |
Why?
|
| Genome, Viral | 1 | 2020 | 122 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2020 | 89 | 0.160 |
Why?
|
| Evolution, Molecular | 1 | 2021 | 298 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 178 | 0.160 |
Why?
|
| HIV-1 | 1 | 2024 | 692 | 0.150 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 738 | 0.150 |
Why?
|
| Microsatellite Repeats | 1 | 2018 | 38 | 0.150 |
Why?
|
| Immunity, Innate | 1 | 2024 | 774 | 0.150 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 623 | 0.150 |
Why?
|
| Child | 4 | 2021 | 4215 | 0.140 |
Why?
|
| Whole Genome Sequencing | 3 | 2024 | 63 | 0.140 |
Why?
|
| Tanzania | 3 | 2024 | 19 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2018 | 197 | 0.140 |
Why?
|
| Haplotypes | 3 | 2022 | 115 | 0.130 |
Why?
|
| Genetic Variation | 3 | 2024 | 357 | 0.120 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 43 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1123 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2015 | 308 | 0.110 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 2024 | 15 | 0.110 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2024 | 8 | 0.100 |
Why?
|
| Prevalence | 3 | 2021 | 1262 | 0.100 |
Why?
|
| Zambia | 2 | 2023 | 9 | 0.100 |
Why?
|
| Drosophila | 1 | 2015 | 422 | 0.100 |
Why?
|
| Proguanil | 2 | 2022 | 4 | 0.090 |
Why?
|
| Infant | 3 | 2020 | 1496 | 0.090 |
Why?
|
| Gene Frequency | 2 | 2023 | 118 | 0.090 |
Why?
|
| Genomics | 2 | 2024 | 322 | 0.090 |
Why?
|
| Geography | 2 | 2021 | 32 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2020 | 1802 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2520 | 0.090 |
Why?
|
| Female | 6 | 2023 | 30926 | 0.090 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 680 | 0.080 |
Why?
|
| Adolescent | 4 | 2021 | 5866 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 2390 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 1153 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2015 | 627 | 0.080 |
Why?
|
| Male | 5 | 2021 | 27952 | 0.080 |
Why?
|
| Animals | 5 | 2024 | 19705 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1192 | 0.070 |
Why?
|
| Africa South of the Sahara | 1 | 2024 | 16 | 0.060 |
Why?
|
| Insecticide Resistance | 1 | 2024 | 10 | 0.060 |
Why?
|
| Metagenomics | 1 | 2024 | 22 | 0.060 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2024 | 20 | 0.060 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2024 | 12 | 0.060 |
Why?
|
| Citric Acid Cycle | 1 | 2024 | 27 | 0.060 |
Why?
|
| Karyopherins | 1 | 2024 | 7 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2024 | 88 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2021 | 3090 | 0.060 |
Why?
|
| Piperazines | 1 | 2024 | 74 | 0.060 |
Why?
|
| Spatial Analysis | 1 | 2023 | 7 | 0.050 |
Why?
|
| Phylogeny | 1 | 2024 | 337 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2024 | 191 | 0.050 |
Why?
|
| Ligases | 1 | 2023 | 26 | 0.050 |
Why?
|
| Asymptomatic Infections | 1 | 2023 | 18 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2023 | 111 | 0.050 |
Why?
|
| Ethylenediamines | 1 | 2022 | 1 | 0.050 |
Why?
|
| Asparagine | 1 | 2022 | 24 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2023 | 66 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 121 | 0.050 |
Why?
|
| Ethiopia | 1 | 2021 | 4 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 194 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 411 | 0.050 |
Why?
|
| Antigens, Protozoan | 1 | 2021 | 43 | 0.050 |
Why?
|
| Cytochromes b | 1 | 2021 | 2 | 0.050 |
Why?
|
| Selection, Genetic | 1 | 2021 | 71 | 0.050 |
Why?
|
| Atovaquone | 1 | 2021 | 3 | 0.050 |
Why?
|
| Cambodia | 1 | 2021 | 20 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2022 | 186 | 0.050 |
Why?
|
| Young Adult | 2 | 2021 | 4290 | 0.040 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2020 | 9 | 0.040 |
Why?
|
| Parasitemia | 1 | 2020 | 35 | 0.040 |
Why?
|
| Molecular Probes | 1 | 2020 | 29 | 0.040 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2020 | 17 | 0.040 |
Why?
|
| Kenya | 1 | 2020 | 79 | 0.040 |
Why?
|
| Ghana | 1 | 2020 | 10 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 293 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 56 | 0.040 |
Why?
|
| Islands | 1 | 2020 | 1 | 0.040 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2020 | 12 | 0.040 |
Why?
|
| Haploidy | 1 | 2020 | 10 | 0.040 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2019 | 5 | 0.040 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2019 | 11 | 0.040 |
Why?
|
| Travel | 1 | 2020 | 37 | 0.040 |
Why?
|
| Adult | 3 | 2021 | 15771 | 0.040 |
Why?
|
| Gene Library | 1 | 2020 | 98 | 0.040 |
Why?
|
| Demography | 1 | 2020 | 170 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2020 | 223 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2021 | 253 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 123 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 395 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 550 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 1381 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 335 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2020 | 256 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 749 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 442 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 1142 | 0.030 |
Why?
|
| HIV Infections | 1 | 2024 | 915 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2024 | 1473 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 1245 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 89 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 133 | 0.030 |
Why?
|
| Neuroglia | 1 | 2015 | 79 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2015 | 288 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2226 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2387 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2023 | 2906 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 620 | 0.020 |
Why?
|
| Mice | 1 | 2024 | 10317 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1472 | 0.020 |
Why?
|
| Brain | 1 | 2015 | 1495 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 16452 | 0.010 |
Why?
|